Zurueck zur Suche

Reporte zur Charge EN66208

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
1Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden

VAERS 2701238

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN66208

kritisch
Staat
-
Alter
-
Geschlecht
M
Eingang
25.10.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Actor died from receiving a COVID-19 Vaccine from a specific lot number; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). A male patient received bnt162b2 (BNT162B2), as dose number unknown, single (Lot number: EN66208, Expiration Date: 30Jun2021) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "Actor died from receiving a COVID-19 Vaccine from a specific lot number". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Clinical course: A call from the reporter was received complaining about why Pfizer has not called patients back from receiving a COVID-19 vaccine from a specific lot number. Reporter was not the patient, she was just calling to complain. All she stated that why haven't Pfizer called, did a recall for the patients who received the COVID-19 Vaccine Lot# EN66208. Patients were dying and was stating that an actor died from receiving the shot (Clarified as Pfizer COVID-19 Vaccine) from this particular batch number. Reported COVID-19 Vaccine expiration date was 30Jun2021.; Reported Cause(s) of Death: Actor died from receiving a COVID-19 Vaccine from a specific LOT number

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-